US Broker Ratings

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating a 26% Potential Upside in Healthcare

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, particularly within the medical care facilities industry. This German-based company, with a market capitalization of..

IDEXX Laboratories, Inc. (IDXX) Stock Report: Evaluating a 29.96% Potential Upside in the Diagnostics Leader

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the diagnostics and research sector, is making waves in the healthcare industry with its innovative solutions for veterinary and water quality..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A 14.66% Upside in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN) is making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $13.56 billion, this UK-based company..

Veeva Systems Inc. (VEEV) Stock Analysis: Healthcare Tech Leader with a 47% Upside Potential

Veeva Systems Inc. (NYSE: VEEV), a prominent player in the healthcare sector, specializes in providing cloud-based software solutions tailored for the life sciences industry. With a market capitalization of $30.26..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 24.50% Potential Upside in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a leader in the healthcare sector’s medical distribution industry, is currently showcasing intriguing investment potential. With a market capitalization of $8.51 billion, the company operates..

Tempus AI, Inc. (TEM): Investor Outlook on a Healthcare Tech Innovator with 65.95% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a leading player in the healthcare technology sector, is capturing investor attention with its impressive growth trajectory and potential upside of 65.95% based on analyst..

Repligen Corporation (RGEN) Stock Analysis: Exploring a Potential 63% Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers an intriguing investment opportunity for those eyeing growth in the..

Bio-Techne Corp (TECH) Stock Analysis: 46% Potential Upside Beckons Investors

Bio-Techne Corporation (NASDAQ: TECH), a leading player in the biotechnology sector, has captured investor interest with a significant potential upside of 46.17%. This Minneapolis-based company, with a market cap of..

Solventum Corporation (SOLV) Stock Analysis: Exploring a 37% Potential Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV), a prominent player in the healthcare sector, is capturing investor interest with its notable potential upside of 37.07%. As a company that develops and commercializes innovative..

Moderna, Inc. (MRNA) Stock Analysis: Understanding the Biotech Giant’s Upside Potential and Current Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent name in the biotechnology sector, has been a significant player in the global healthcare landscape, particularly with its pioneering work in mRNA technology. Despite..

Incyte Corporation (INCY) Investor Outlook: Exploring a 18.52% Potential Upside Amid Robust Growth

Incyte Corporation (NASDAQ: INCY), a leading player in the biotechnology sector, presents a compelling narrative for investors seeking exposure to the healthcare industry. With a market capitalization of $18.07 billion,..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Revenue Growth Amid Valuation Concerns

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is making waves with its innovative cancer screening and diagnostic test products. Based in..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a Potential 30% Upside with Strong Buy Ratings

For investors eyeing opportunities within the biopharmaceutical sector, Ascendis Pharma A/S (NASDAQ: ASND) stands out with a compelling narrative driven by innovative therapies and a robust market position. With a..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: 32.58% Potential Upside Promises Growth for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the global healthcare sector, has recently caught the attention of investors with its substantial growth potential. Operating primarily in the realm..

HealthEquity, Inc. (HQY) Stock Analysis: A Deep Dive into the 37.77% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the Health Information Services industry, offers investors a compelling opportunity with a potential upside of 37.77%. As the company stands at the..

Centene Corporation (CNC) Stock Analysis: Exploring a 25.51% Upside Potential

Centene Corporation (CNC), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With its headquarters in Saint Louis, Missouri,..

Baxter International Inc. (BAX) Stock Analysis: Navigating A 33% Potential Upside Amidst Mixed Financial Signals

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is currently navigating complex market dynamics that present both challenges and opportunities for investors. With a current market cap..

Insulet Corporation (PODD) Stock Analysis: A 55.93% Upside Potential for Investors in the Healthcare Sector

Insulet Corporation (NASDAQ: PODD), a prominent player in the medical devices industry, is drawing significant attention from investors thanks to its innovative insulin delivery systems. With a market capitalization of..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a Stable Path in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a stalwart in the healthcare sector, has demonstrated resilience amid challenging market conditions. With a market capitalization of $16.83 billion, Hologic specializes in developing and supplying..

The Cooper Companies, Inc. (COO): Investor Outlook with a 30% Upside Potential

The Cooper Companies, Inc. (NYSE: COO) presents a compelling opportunity for investors looking to tap into the robust healthcare sector. With a market capitalization of $13.65 billion, Cooper is a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds